SC0002 Subcloning bundled withgene synthesis:mDMT11A_pcDNA3.1(+)Vector: pcDNA3.1(+)( from… and 1 more item

The University of Virginia awarded contract A207_PO-0464241-V2 to GenScript ProBio USA Inc. on August 28, 2026. The cumulative contract value is $238. While the specific products and services to be delivered under this award are not detailed in the provided documentation, GenScript ProBio USA Inc. is a biotechnology firm specializing in synthetic biology and related research services. Based on the awardee's core business operations, the contract likely involves provision of biological research materials, reagents, or related scientific services to support the University of Virginia's research initiatives.

The contract does not specify a defined period of performance, place of performance details beyond the University of Virginia in Virginia, or annual value separate from the cumulative contract value. The minimal cumulative value of $238 suggests this may represent a purchase order or task order under an existing master service agreement, a pilot project, or a small-value procurement. Additional contract documentation would be necessary to determine the specific scope of work, deliverables, performance timelines, and the full commercial relationship between the University of Virginia and GenScript ProBio USA Inc.